(Reuters) – Medical equipment maker Steris lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar.
The Dublin-based company lowered its fiscal 2025 adjusted profit to the range of $9.05 to $9.15 per share, from a prior forecast of $9.05 to $9.25 per share.
“This outlook does not reflect any potential impact from new tariffs.” the company said.
Manufacturers of medical devices have been benefiting from elevated demand for elective surgical procedures in the United States, especially among older adults.
Steris, which produces surgical instruments, reported quarterly revenue of $1.37 billion, slightly below analysts’ estimates of $1.38 billion, according to data compiled by LSEG.
The healthcare segment of the company, which provides sterilization products to healthcare providers, saw its quarterly revenue rise 7% in the third quarter ended December 31, to $976.0 million.
On an adjusted basis, the company reported a profit of $2.32 per share, which was in line with analysts’ expectations.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
Comments